[fcb5af]: / literature / by_gene / PRKDC.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 31516393 10.1186/s12935-019-0954-3 2022 Development of transplantable B-cell lymphomas in the MHC-defined miniature swine model. PRKDC
2 33615686 10.1002/kjm2.12352 2022 The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway. PRKDC
3 33974997 10.1016/j.ymthe.2021.05.006 2022 Self-driving armored CAR-T cells overcome a suppressive milieu and eradicate CD19<sup>+</sup> Raji lymphoma in preclinical models. PRKDC
4 34158342 10.1158/1535-7163.MCT-21-0074 2022 Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV<sup>+</sup> Human Primary B-cells. PRKDC
5 35255940 10.1186/s12967-022-03317-7 2022 Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population. PRKDC
6 35400595 10.1016/j.jcyt.2022.02.006 2022 CCR7 expression in CD19 chimeric antigen receptor-engineered natural killer cells improves migration toward CCL19-expressing lymphoma cells and increases tumor control in mice with human lymphoma. PRKDC
7 35411036 10.1038/s41388-022-02301-1 2022 Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma. PRKDC
8 35659513 10.1016/j.canlet.2022.215762 2022 CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia. PRKDC
9 30546948 10.1080/2162402X.2018.1512455 2021 Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,<i>in-vitro</i> proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model. PRKDC
10 31736441 10.1177/0300985819882631 2021 Morphologic and Immunohistochemical Characterization of Spontaneous Lymphoma/Leukemia in NSG Mice. PRKDC
11 32202225 10.1177/0300985820913265 2021 Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid Tumors. PRKDC
12 32938796 10.1126/scitranslmed.aba5942 2021 B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destruction. PRKDC
13 33106625 10.1038/s41375-020-01068-2 2021 Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity. PRKDC
14 33593826 10.1136/jitc-2020-001524 2021 Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model. PRKDC
15 30623002 10.1016/j.omtm.2018.11.010 2020 Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions. PRKDC
16 31967647 10.1093/jpids/piaa005 2020 A 4-Year-Old Boy With Prolonged Cough and Fever. PRKDC
17 32103174 10.1038/s41586-020-2041-2 2020 DNA-PKcs has KU-dependent function in rRNA processing and haematopoiesis. PRKDC
18 29221181 10.18632/oncotarget.21619 2019 Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome <i>vs. HTLV-1<sup>+</sup></i> leukemic cell lines. PRKDC
19 29702521 10.1097/MOH.0000000000000433 2019 DNA damage pathways and B-cell lymphomagenesis. PRKDC
20 28355107 10.1177/0300985817698210 2018 Pathology of Aging in NOD scid gamma Female Mice. PRKDC
21 28465297 10.1158/1541-7786.MCR-16-0305 2018 Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences. PRKDC
22 29070697 10.1126/scitranslmed.aao1214 2018 Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways. PRKDC
23 30159932 10.1111/vde.12650 2018 Phenotypic analysis of mice xenografted with canine epitheliotropic cutaneous T-cell lymphoma cells. PRKDC
24 27181405 10.1016/j.ajpath.2016.03.012 2017 Intrahepatic Xenograft of Cutaneous T-Cell Lymphoma Cell Lines: A Useful Model for Rapid Biological and Therapeutic Evaluation. PRKDC
25 27235137 10.1182/blood-2016-02-700328 2017 Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia. PRKDC
26 27373144 10.1016/j.dnarep.2016.06.001 2017 Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways. PRKDC
27 28331319 10.2147/IJN.S127575 2017 Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential. PRKDC
28 28698205 10.1182/blood-2017-01-764316 2017 An Fc-engineered CD19 antibody eradicates MRD in patient-derived <i>MLL</i>-rearranged acute lymphoblastic leukemia xenografts. PRKDC
29 25678421 10.1016/j.jcpa.2014.11.008 2016 Reconstruction of canine diffuse large B-cell lymphoma gene regulatory network: detection of functional modules and hub genes. PRKDC
30 25868101 10.1097/BRS.0000000000000821 2016 Apoptosis in human compressive myelopathy due to metastatic neoplasia. PRKDC
31 26446488 10.1038/ncomms9325 2016 LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. PRKDC
32 26546522 2016 Hoechst 33342 Staining Identifies the Progenitor Side Population in NOD.Cg-PrkdcscidIL2rgtmWjl/Sz Mice Harboring Pediatric Leukemias. PRKDC
33 26869395 10.1182/blood-2015-08-665034 2016 The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts. PRKDC
34 27489678 10.1177/2050313X14568698 2016 Spontaneous development of neoplasms in severe combined immunodeficient mice. PRKDC
35 24586935 10.1371/journal.pone.0089649 2015 Ectopic TLX1 expression accelerates malignancies in mice deficient in DNA-PK. PRKDC
36 24740260 10.1371/journal.pone.0093568 2015 The progeroid phenotype of Ku80 deficiency is dominant over DNA-PKCS deficiency. PRKDC
37 24956209 2015 Irradiated compared with nonirradiated NSG mice for the development of a human B-cell lymphoma model. PRKDC
38 25359989 10.1182/blood-2014-05-572743 2015 Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice. PRKDC
39 23232667 10.3892/ijo.2012.1734 2014 Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model. PRKDC
40 23761041 10.1126/scitranslmed.3005814 2014 Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors. PRKDC
41 24589354 10.1016/j.etp.2014.01.006 2014 Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse. PRKDC
42 24862967 10.1038/labinvest.2014.61 2014 Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research. PRKDC
43 22614020 10.1038/onc.2012.199 2013 PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis. PRKDC
44 23022380 10.1016/j.molcel.2012.08.022 2013 NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. PRKDC
45 23526331 10.1002/ijc.28170 2013 Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome. PRKDC
46 23960188 10.1084/jem.20122842 2013 DNA repair genes are selectively mutated in diffuse large B cell lymphomas. PRKDC
47 22529269 10.1084/jem.20111437 2012 Artemis C-terminal region facilitates V(D)J recombination through its interactions with DNA Ligase IV and DNA-PKcs. PRKDC
48 20629733 10.1111/j.1600-0625.2010.01138.x 2011 A novel xenograft model of cutaneous T-cell lymphoma. PRKDC
49 21512274 10.1538/expanim.60.181 2011 Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness. PRKDC
50 19773279 10.1136/oem.2008.044024 2010 Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. PRKDC
51 20739953 10.1038/leu.2010.184 2010 High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. PRKDC
52 20813000 10.1111/j.1365-2141.2010.08364.x 2010 Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. PRKDC
53 19573080 10.1111/j.1365-2141.2009.07790.x 2009 Common genetic variants in candidate genes and risk of familial lymphoid malignancies. PRKDC
54 18507045 2008 18F-FDG small animal PET for early detection of human anaplastic large cells lymphoma xenograft in immunocompromised mice. PRKDC
55 18688847 10.1002/ijc.23772 2008 Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains. PRKDC
56 16000400 10.1093/carcin/bgi175 2007 The association of DNA-dependent protein kinase activity with chromosomal instability and risk of cancer. PRKDC
57 15105825 10.1038/sj.embor.7400127 2005 Shorter telomeres, accelerated ageing and increased lymphoma in DNA-PKcs-deficient mice. PRKDC
58 15215044 10.1016/j.yexmp.2004.02.001 2004 Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies. PRKDC
59 12970738 10.1038/sj.onc.1206826 2003 Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma. PRKDC
60 11953863 10.1038/sj.bjc.6600191 2002 Phosphorothioate oligonucleotides, suramin and heparin inhibit DNA-dependent protein kinase activity. PRKDC
61 11160753 10.1128/JVI.75.5.2475-2481.2001 2001 EBNA-LP associates with cellular proteins including DNA-PK and HA95. PRKDC
62 11264175 10.1182/blood.v97.7.2084 2001 BCR-ABL down-regulates the DNA repair protein DNA-PKcs. PRKDC
63 11292837 10.1093/nar/29.8.1653 2001 Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells. PRKDC
64 11439324 10.1038/sj.onc.1204497 2001 Variations in Prkdc encoding the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) and susceptibility to radiation-induced apoptosis and lymphomagenesis. PRKDC
65 10395545 10.1016/s0960-9822(99)80311-x 1999 Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. PRKDC
66 9426062 1998 The radiosensitive cell line 180BR is not defective in the major DNA damage-sensing proteins. PRKDC
67 9657696 10.1021/bi980198o 1998 Implication of DNA-dependent protein kinase in an early, essential, local phosphorylation event during end-joining of DNA double-strand breaks in vitro. PRKDC
68 9688310 10.1002/(sici)1097-0215(19980831)77:5&lt;755::aid-ijc15&gt;3.0.co;2-0 1998 Resistance to etoposide-induced apoptosis in a Burkitt's lymphoma cell line. PRKDC
69 9377575 1997 A DNA double-strand break defective fibroblast cell line (180BR) derived from a radiosensitive patient represents a new mutant phenotype. PRKDC
70 9398855 10.1038/ng1297-479 1997 Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. PRKDC
71 9398856 10.1038/ng1297-483 1997 DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus. PRKDC
72 8086496 10.1016/0167-4889(94)90234-8 1994 Molecular properties, substrate specificity and regulation of DNA-dependent protein kinase from Raji Burkitt's lymphoma cells. PRKDC
73 1597196 10.1111/j.1432-1033.1992.tb16964.x 1992 DNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoprotein. PRKDC